SEC Form 4 · accession 0001209191-15-052225
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nikin Patel
Officer — COO · Director
Period of report
Jun 9, 2015
Accepted (ET)
Jun 11, 2015 · 2:44 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| JNP Stock on Open MarketF1 | Jun 9, 2015 | P | 13,500 | $7.52 | A | 184,384 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at an average price of $7.52. The price reported above reflects the weighted-average purchase price. The reporting person hereby undertakes to provide upon further request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction were effected.